4
Changes in Ownership
Yarrow Bioscience, Inc. Filed Acc 0001209191-21-047407
Options or other derivatives
- Director acquired 20,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Bright Rex · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-07-19 | Grant or award : show line 1 in the form Stock Options | +20,500 | 20,500 | D |
Loading xslF345X03/doc4.xml…